Individualized Infiximab Dosing-Proof of Concept Study
NCT02027727
·
clinicaltrials.gov ↗
UNKNOWN
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Inflammatory Bowel Diseases
Interventions
OTHER:
No Intervention
Sponsor
Cedars-Sinai Medical Center